Feasibility of Aromatherapy in an Awake Craniotomy Environment

Who is this study for? Adult patients with brain tumors
What treatments are being studied? Lavender
Status: Completed
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a traditional general anesthetic technique. Though many patients tolerate awake cranial surgery well, recent studies found that roughly 30% of patients experience moderate to severe pain and anxiety, while 50% report moderate fear and 11% report severe fear. Therefore, alternative methods to mitigate pain, anxiety, and fear are needed. In this study, the investigators will employ lavender aromatherapy to reduce anxiety and improve the satisfaction with pain control.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Any adult patient aged 18 and older undergoing awake cranial neurosurgery

Locations
United States
Wisconsin
Aurora Health Care, Aurora St. Luke's Medical Center
Milwaukee
Time Frame
Start Date: 2018-04-03
Completion Date: 2019-06-12
Participants
Target number of participants: 40
Treatments
Experimental: Treatment with Lavender
Lavender (Lavandula angustifolia) aromatherapy will be administered at regular intervals using a nasal inhaler.
Related Therapeutic Areas
Sponsors
Leads: Wake Forest University Health Sciences

This content was sourced from clinicaltrials.gov